Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing. - PubMed - NCBI

Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing. - PubMed - NCBI

JAMA. 2018 Jun 19;319(23):2377-2378. doi: 10.1001/jama.2018.5330.

Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.

Gill J1, Obley AJ2, Prasad V1,3.

Author information

PMID:

 

29800087

 

DOI:

 

10.1001/jama.2018.5330

[Indexed for MEDLINE]